Journal of Clinical Psychopharmacology
container_f5cmd7td4jhe5es63ylbzzlnca
Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins
Showing first 25 out of 8,675 results
Neurophysiological Effects of Bitopertin in Schizophrenia
Joshua T. Kantrowitz, Karen A. Nolan, Michael L. Epstein, Nayla Lehrfeld, Constance Shope, Eva Petkova, Daniel C. Javitt
2017
|
Journal of Clinical Psychopharmacology
doi:10.1097/jcp.0000000000000722 pmcid:PMC5492956
Clinical Outcomes of Concomitant Use of Warfarin and Selective Serotonin Reuptake Inhibitors
Yaa-Hui Dong, Katsiaryna Bykov, Niteesh K. Choudhry, Macarius M. Donneyong, Krista F. Huybrechts, Raisa Levin, Sebastian Schneeweiss, Joshua J. Gagne
2017
|
Journal of Clinical Psychopharmacology
doi:10.1097/jcp.0000000000000658 pmid:28129313 wikidata:Q40361849
Metabolic Syndrome and Its Potential Effect on Treatment Response to Aripiprazole
David E. Kemp, James M. Eudicone, Robert D. McQuade, Jessie S. Chambers, Ross A. Baker
2010
|
Journal of Clinical Psychopharmacology
doi:10.1097/jcp.0b013e3181f0569f pmcid:PMC3904751 wikidata:Q37524755
An Open-Label Pilot Study of Combined Augmentation With Creatine Monohydrate and 5-Hydroxytryptophan for Selective Serotonin Reuptake Inhibitor– or Serotonin-Norepinephrine Reuptake Inhibitor–Resistant Depression in Adult Women
Brent M. Kious, Hana Sabic, Young-Hoon Sung, Douglas G. Kondo, Perry Renshaw
2017
|
Journal of Clinical Psychopharmacology
doi:10.1097/jcp.0000000000000754 pmcid:PMC5578880 wikidata:Q38645491
Recurrent Catatonia in Parkinson Disease
Burç Çağri Poyraz, Cana Aksoy Poyraz, Ahmet Yassa, Mehmet Kemal Arikan, Ayşegül Gündüz, Güneş Kiziltan
2016
|
Journal of Clinical Psychopharmacology
doi:10.1097/jcp.0000000000000443 pmid:26658081
My Kingdom for a Denominator, or at Least Enough Data
Richard I. Shader, David L. Streiner
2020
|
Journal of Clinical Psychopharmacology
doi:10.1097/jcp.0000000000001219 pmcid:PMC7253034
COMT Val158Met, BDNF Val66Met, and OPRM1 Asn40Asp and Methamphetamine Dependence Treatment Response
Keith G. Heinzerling, James T. McCracken, Aimee-Noelle Swanson, Lara A. Ray, Steven J. Shoptaw
2012
|
Journal of Clinical Psychopharmacology
doi:10.1097/jcp.0b013e318240a48e pmcid:PMC3597465 wikidata:Q36684436
Pathological Gambling Associated With Aripiprazole or Dopamine Replacement Therapy
Marie Grall-Bronnec, Anne Sauvaget, Fanny Perrouin, Juliette Leboucher, François Etcheverrigaray, Gaëlle Challet-Bouju, Louise Gaboriau, Pascal Derkinderen, Pascale Jolliet, Caroline Victorri-Vigneau
2016
|
Journal of Clinical Psychopharmacology
doi:10.1097/jcp.0000000000000444 pmcid:PMC4700874 wikidata:Q34674778
Decreased Mitochondrial Function and Increased Brain Inflammation in Bipolar Disorder and Other Neuropsychiatric Diseases
Theoharis C. Theoharides, Bodi Zhang, Pio Conti
2011
|
Journal of Clinical Psychopharmacology
doi:10.1097/jcp.0b013e318239c190 pmid:22020358 wikidata:Q48824794
A Double-Blind, Placebo-Controlled Pilot Trial of Quetiapine for the Treatment of Type A and Type B Alcoholism
Kyle M. Kampman, Helen M. Pettinati, Kevin G. Lynch, Tom Whittingham, Wayne Macfadden, Charles Dackis, Carlos Tirado, David W. Oslin, Thorne Sparkman, Charles P. O'Brien
2007
|
Journal of Clinical Psychopharmacology
doi:10.1097/jcp.0b013e3180ca86e5 pmcid:PMC3193934 wikidata:Q35354770
Lithium Augmentation of Nortriptyline for Subjects Resistant to Multiple Antidepressants
Andrew A. Nierenberg, George I. Papakostas, Timothy Petersen, Heidi D. Montoya, John J. Worthington, Joyce Tedlow, Jonathan E. Alpert, Maurizio Fava
2003
|
Journal of Clinical Psychopharmacology
doi:10.1097/00004714-200302000-00013 pmid:12544380
The Relationship Between Prolactin Levels and Glucose Homeostasis in Antipsychotic-treated Schizophrenic Patients
Oliver D. Howes, Shubulade Smith, Fiona P. Gaughran, Stephanie A. Amiel, Robin M. Murray, Lyn S. Pilowsky
2006
|
Journal of Clinical Psychopharmacology
doi:10.1097/01.jcp.0000239791.91330.48 pmcid:PMC3686224 wikidata:Q36939324
Time-Dependent Clearance Decrements of Fluvoxamine in Depressed Inpatients
Walter W. van den Broek, Tom K. Birkenh??ger, Paul G.H. Mulder, Ron A.A. Mathot, Jan A. Bruijn, Peter Moleman
2007
|
Journal of Clinical Psychopharmacology
doi:10.1097/01.jcp.0000264978.71743.bd pmid:17414260
A Preliminary Study of Bupropion Sustained-Release for Smoking Cessation in Patients With Chronic Posttraumatic Stress Disorder
Michael A. Hertzberg, Scott D. Moore, Michelle E. Feldman, Jean C. Beckham
2001
|
Journal of Clinical Psychopharmacology
doi:10.1097/00004714-200102000-00017 pmid:11199956 wikidata:Q31995809
A 12-Month Open-Label Extension Study of the Safety and Tolerability of Lisdexamfetamine Dimesylate for Major Depressive Disorder in Adults
Cynthia Richards, Dan V. Iosifescu, Rajnish Mago, Elias Sarkis, Brooke Geibel, Matthew Dauphin, Roger S. McIntyre, Richard Weisler, Olga Brawman-Mintzer, Joan Gu, Manisha Madhoo
2018
|
Journal of Clinical Psychopharmacology
doi:10.1097/jcp.0000000000000897 pmcid:PMC6039401
The Role of the Family and Improvement in Treatment Maintenance, Adherence, and Outcome for Schizophrenia
Ira D. Glick, Anya H. Stekoll, Spencer Hays
2011
|
Journal of Clinical Psychopharmacology
doi:10.1097/jcp.0b013e31820597fa pmid:21192148
Aripiprazole Lauroxil
Marjie L. Hard, Richard J. Mills, Brian M. Sadler, Ryan Z. Turncliff, Leslie Citrome
2017
|
Journal of Clinical Psychopharmacology
doi:10.1097/jcp.0000000000000691 pmcid:PMC5400404 wikidata:Q38871120
A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Naltrexone to Counteract Antipsychotic-Associated Weight Gain
Cenk Tek, Joseph Ratliff, Erin Reutenauer, Rohan Ganguli, Stephanie S. O'Malley
2014
|
Journal of Clinical Psychopharmacology
doi:10.1097/jcp.0000000000000192 pmcid:PMC4149840 wikidata:Q34111646
Hearts and Minds
George Joy, Eromona Whiskey, Mark Bolstridge, Alejandro Porras-Segovia, Theresa A. McDonagh, Carla M. Plymen, Sukhi S. Shergill
2017
|
Journal of Clinical Psychopharmacology
doi:10.1097/jcp.0000000000000792 pmid:29049078 wikidata:Q47593873
Antidepressant Agents and Suicide Death Among US Department of Veterans Affairs Patients in Depression Treatment
Marcia Valenstein, Hyungjin Myra Kim, Dara Ganoczy, Daniel Eisenberg, Paul N. Pfeiffer, Karen Downing, Katherine Hoggatt, Mark Ilgen, Karen L. Austin, Kara Zivin, Frederic C. Blow, John F. McCarthy
2012
|
Journal of Clinical Psychopharmacology
doi:10.1097/jcp.0b013e3182539f11 pmcid:PMC3517726 wikidata:Q36454588
Sources of Unreliability in Depression Ratings
Kenneth A. Kobak, Brianne Brown, Ian Sharp, Hollie Levy-Mack, Kurrie Wells, Felice Okum, Janet B.W. Williams
2009
|
Journal of Clinical Psychopharmacology
doi:10.1097/jcp.0b013e318192e4d7 pmid:19142114 wikidata:Q44686843
Exploring Nitrous Oxide as Treatment of Mood Disorders
Peter Nagele, Charles F. Zorumski, Charles Conway
2018
|
Journal of Clinical Psychopharmacology
doi:10.1097/jcp.0000000000000837 pmcid:PMC5825282 wikidata:Q47649037
A Single-Blinded Case-Control Study of Memantine in Severe Obsessive-Compulsive Disorder
S. Evelyn Stewart, Eric A. Jenike, Dianne M. Hezel, Denise Egan Stack, Nicholas H. Dodman, Louis Shuster, Michael A. Jenike
2010
|
Journal of Clinical Psychopharmacology
doi:10.1097/jcp.0b013e3181c856de pmid:20075645 wikidata:Q39909632
A Pilot Study of Adjunctive Atomoxetine Treatment to Second-Generation Antipsychotics for Cognitive Impairment in Schizophrenia
Joseph I. Friedman, David Carpenter, Jing Lu, Jin Fan, Cheuk Y. Tang, Leonard White, Michael Parrella, Stephanie Bowler, Zeinab Elbaz, Lauren Flanagan, Philip D. Harvey
2008
|
Journal of Clinical Psychopharmacology
doi:10.1097/jcp.0b013e318161318f pmid:18204342 wikidata:Q46801821
A Randomized, Controlled, Pilot Study of Acamprosate Added to Escitalopram in Adults With Major Depressive Disorder and Alcohol Use Disorder
Janet Witte, Kate Bentley, Anne Eden Evins, Alisabet J. Clain, Lee Baer, Paola Pedrelli, Maurizio Fava, David Mischoulon
2012
|
Journal of Clinical Psychopharmacology
doi:10.1097/jcp.0b013e3182726764 pmcid:PMC3794470 wikidata:Q37224425
« Previous
Showing results 0 — 25 out of 8,675 results
Next »